Elon Musk’s AI chatbot Grok is facing growing backlash from regulators around the world after producing sexualized images of ...

A research team introduces a fully automated, non-destructive phenotyping platform that combines X-ray fluorescence ...

Nearly 1 in 7 adults in the United States lives with chronic kidney disease, a condition that often advances quietly until ...

A comprehensive genetic investigation led by Dr. Feng Liu at Tianjin Medical University General Hospital has uncovered ...

Actio Biosciences, a clinical-stage biotechnology company advancing the translation of genetic insights into novel precision ...

SpliceBio, a clinical-stage genetic medicines company pioneering protein splicing to address diseases caused by mutations in ...

Dosed First Patient in REVEAL Pivotal Trial in the Fourth Quarter of 2025. Additional enrollment continues to advance across ...

Seasoned biotech executive brings over 25 years of leadership experience across financial strategy and operations, investor relations and business development DURHAM, N.C., Jan. 06, 2026 (GLOBE ...

Plants mobilize their immune defenses far earlier than scientists have believed for decades—and through a previously overlooked early signaling mechanism—according to a new study published in Nature ...

U.K. biotech Ikarovec has teamed up with VectorBuilder to work on an eye disease gene therapy that could be administered in a ...

A genetic mutation passed from mother to children in families affected by schizophrenia has now been shown to completely ...

UCSF researchers have discovered a way to identify deadly lung infections with improved accuracy by pairing AI with a unique ...